{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:42:02Z","timestamp":1782963722869,"version":"3.54.5"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-23809-7","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T07:46:21Z","timestamp":1753861581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A scoping review on HCV screening strategies: population to screen and the test types"],"prefix":"10.1186","volume":"25","author":[{"given":"Saro Abdella","family":"Abrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Radley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Inglis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelalem","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeje","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getahun","family":"Fetensa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andargachew","family":"Mulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wondwossen","family":"Amogne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawit","family":"Wolday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"issue":"2","key":"23809_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S2222-1808(14)60322-4","volume":"4","author":"U Saeed","year":"2014","unstructured":"Saeed U, Waheed Y, Ashraf M. Hepatitis B and hepatitis C viruses: a review of viral genomes, viral induced host immune responses, genotypic distributions and worldwide epidemiology. Asian Pac J Trop Dis. 2014;4(2):88\u201396.","journal-title":"Asian Pac J Trop Dis"},{"issue":"6","key":"23809_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6906a1","volume":"69","author":"AC Moorman","year":"2020","unstructured":"Moorman AC, de Perio MA, Goldschmidt R, Chu C, Kuhar D, Henderson DK, et al. Testing and clinical management of health care personnel potentially exposed to hepatitis C virus\u2014CDC guidance, united states, 2020. MMWR Recommendations Rep. 2020;69(6):1.","journal-title":"MMWR Recommendations Rep"},{"key":"23809_CR3","unstructured":"WHO. Hepatitis C Fact Sheet. Updated 2024. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"23809_CR4","doi-asserted-by":"crossref","unstructured":"Obadahn O, Kamal SM, Hepatitis C. Virus in Sub-Saharan africa. Hepatitis C in developing countries. Elsevier; 2018. pp. 71\u201381.","DOI":"10.1016\/B978-0-12-803233-6.00007-2"},{"key":"23809_CR5","doi-asserted-by":"crossref","unstructured":"Deress T, Million Y, Belachew T, Jemal M, Girma M. Seroprevalence of hepatitis C viral infection in Ethiopia: a systematic review and meta-analysis. The Scientific World Journal. 2021;2021.","DOI":"10.1155\/2021\/8873389"},{"key":"23809_CR6","unstructured":"WHO. Hepatitis C Virus Self-testing. Updated 2021. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240031128."},{"key":"23809_CR7","volume-title":"WHO guidelines on hepatitis B and","author":"WH Organization","year":"2017","unstructured":"Organization WH. WHO guidelines on hepatitis B and. C testing: World Health Organization; 2017."},{"key":"23809_CR8","unstructured":"CDC. Testing Recommendations for Hepatitis C Virus Infection. Updated 2025. Available from:\u00a0https:\/\/www.cdc.gov\/hepatitis-c\/hcp\/diagnosis-testing\/index.html."},{"key":"23809_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/liv.13012","volume":"36","author":"ML Shiffman","year":"2016","unstructured":"Shiffman ML. Universal screening for chronic hepatitis C virus. Liver Int. 2016;36:62\u20136.","journal-title":"Liver Int"},{"issue":"3","key":"23809_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.5811\/westjem.2021.1.49667","volume":"22","author":"JS Ford","year":"2021","unstructured":"Ford JS, Chechi T, Toosi K, Mahmood B, Meehleis D, Otmar M, et al. Universal screening for hepatitis C virus in the ED using a best practice advisory. Western J Emerg Med. 2021;22(3):719.","journal-title":"Western J Emerg Med"},{"issue":"10","key":"23809_CR11","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/cid\/ciy586","volume":"67","author":"R Jhaveri","year":"2018","unstructured":"Jhaveri R, Broder T, Bhattacharya D, Peters MG, Kim AY, Jonas MM. Universal screening of pregnant women for hepatitis C: the time is now. Clin Infect Dis. 2018;67(10):1493\u20137.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"23809_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3233\/NPM-15915024","volume":"8","author":"W Waruingi","year":"2015","unstructured":"Waruingi W, Mhanna M, Kumar D, Abughali N. Hepatitis C virus universal screening versus risk based selective screening during pregnancy. Journal of Neonatal-Perinatal Medicine. 2015;8(4):371\u20138.","journal-title":"Journal of Neonatal-Perinatal Medicine"},{"issue":"6","key":"23809_CR13","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1080\/09540121.2016.1164290","volume":"28","author":"L Fern\u00e0ndez-L\u00f3pez","year":"2016","unstructured":"Fern\u00e0ndez-L\u00f3pez L, Folch C, Maj\u00f3 X, Gasulla L, Casabona J. Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: a pilot study. AIDS Care. 2016;28(6):712\u20136.","journal-title":"AIDS Care"},{"issue":"3","key":"23809_CR14","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/hep.26113","volume":"57","author":"AY Kim","year":"2013","unstructured":"Kim AY, Nagami EH, Birch CE, Bowen MJ, Lauer GM, McGovern BH. A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users. Hepatology. 2013;57(3):944\u201352.","journal-title":"Hepatology"},{"issue":"3","key":"23809_CR15","first-page":"330","volume":"12","author":"LK Rerambiah","year":"2014","unstructured":"Rerambiah LK, Rerambiah LE, Bengone C, Djoba Siawaya JF. The risk of transfusion-transmitted viral infections at the Gabonese National blood transfusion centre. Blood Transfus. 2014;12(3):330\u20133.","journal-title":"Blood Transfus"},{"issue":"12","key":"23809_CR16","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1136\/oemed-2015-102879","volume":"72","author":"C Westermann","year":"2015","unstructured":"Westermann C, Peters C, Lisiak B, Lamberti M, Nienhaus A. The prevalence of hepatitis C among healthcare workers: a systematic review and meta-analysis. Occup Environ Med. 2015;72(12):880\u20138.","journal-title":"Occup Environ Med"},{"key":"23809_CR17","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00705-020-04716-1","volume":"165","author":"R Rashti","year":"2020","unstructured":"Rashti R, Alavian SM, Moradi Y, Sharafi H, Mohamadi Bolbanabad A, Roshani D, et al. Global prevalence of HCV and\/or HBV coinfections among people who inject drugs and female sex workers who live with HIV\/AIDS: a systematic review and meta-analysis. Arch Virol. 2020;165:1947\u201358.","journal-title":"Arch Virol"},{"key":"23809_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijid.2016.12.019","volume":"55","author":"SM Goldenberg","year":"2017","unstructured":"Goldenberg SM, Montaner J, Braschel M, Socias E, Guillemi S, Shannon K. Dual sexual and drug-related predictors of hepatitis C incidence among sex workers in a Canadian setting: gaps and opportunities for scale-up of hepatitis C virus prevention, treatment, and care. Int J Infect Dis. 2017;55:31\u20137.","journal-title":"Int J Infect Dis"},{"key":"23809_CR19","doi-asserted-by":"crossref","unstructured":"Ghany MG, Morgan TR, Panel AIHCG. Hepatitis C guidance 2019 update: American association for the study of liver diseases\u2013infectious diseases society of America recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology. 2020;71(2):686\u2013721.","DOI":"10.1002\/hep.31060"},{"issue":"7","key":"23809_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"issue":"4","key":"23809_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/ajo.12296","volume":"55","author":"E Wilson","year":"2015","unstructured":"Wilson E, Beckmann M. Antenatal screening for hepatitis C: universal or risk factor based? Aust N Z J Obstet Gynaecol. 2015;55(4):318\u201322.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"25","key":"23809_CR22","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1080\/14767058.2021.1949442","volume":"35","author":"M Susich","year":"2022","unstructured":"Susich M, Hersh AR, Greiner K, Chaiken SR, Caughey AB. A cost-effectiveness analysis of universal hepatitis C screening in all United States pregnancies. J Matern Fetal Neonatal Med. 2022;35(25):7381\u20138.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"23809_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10198-020-01236-2","volume":"22","author":"JFH Eijsink","year":"2021","unstructured":"Eijsink JFH, Al Khayat M, Boersma C, Ter Horst PGJ, Wilschut JC, Postma MJ. Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands. Eur J Health Econ. 2021;22(1):75\u201388.","journal-title":"Eur J Health Econ"},{"issue":"11","key":"23809_CR24","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1093\/cid\/ciz063","volume":"69","author":"A Chaillon","year":"2019","unstructured":"Chaillon A, Reau EB, Martin N. Cost-effectiveness of universal hepatitis C virus screening of pregnant women in the United States. Clin Infect Dis. 2019;69(11):1888\u201395.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"23809_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jinf.2015.01.009","volume":"70","author":"SS El-Kamary","year":"2015","unstructured":"El-Kamary SS, Hashem M, Saleh DA, Ehab M, Sharaf SA, El-Mougy F, et al. Reliability of risk-based screening for hepatitis C virus infection among pregnant women in Egypt. J Infect. 2015;70(5):512\u20139.","journal-title":"J Infect"},{"key":"23809_CR26","doi-asserted-by":"crossref","unstructured":"Boudova S, Mark K, El-Kamary SS. Risk-based hepatitis C screening in pregnancy is less reliable than universal screening: A retrospective chart review. 2018.","DOI":"10.1093\/ofid\/ofy043"},{"issue":"6","key":"23809_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1155\/2014\/190210","volume":"28","author":"J Kapeluto","year":"2014","unstructured":"Kapeluto J, Kadatz M, Wormsbecker A, Sidhu K, Yoshida EM. Screening, detecting and enhancing the yield of previously undiagnosed hepatitis B and C in patients with acute medical admissions to hospital: a pilot project undertaken at the Vancouver General Hospital. Can J Gastroenterol Hepatol. 2014;28(6):315\u20138.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"4","key":"23809_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/jvh.13654","volume":"29","author":"G Wu","year":"2022","unstructured":"Wu G, Zhou A, Kwon S. Integrating hepatitis C virus screening of baby boomers at a community hospital emergency department. J Viral Hepat. 2022;29(4):263\u201370.","journal-title":"J Viral Hepat"},{"issue":"1","key":"23809_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.amepre.2018.08.016","volume":"56","author":"SA Assoumou","year":"2019","unstructured":"Assoumou SA, Wang J, Tasillo A, Eftekhari Yazdi G, Tsui JI, Strick L, et al. Hepatitis C testing and patient characteristics in Washington state\u2019s prisons between 2012 and 2016. Am J Prev Med. 2019;56(1):8\u201316.","journal-title":"Am J Prev Med"},{"issue":"1","key":"23809_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/liv.13930","volume":"39","author":"KA Kim","year":"2019","unstructured":"Kim KA, Chung W, Choi HY, Ki M, Jang ES, Jeong SH. Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population. Liver Int. 2019;39(1):60\u20139.","journal-title":"Liver Int"},{"issue":"1","key":"23809_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12985-019-1157-1","volume":"16","author":"L Liu","year":"2019","unstructured":"Liu L, Xu H, Hu Y, Shang J, Jiang J, Yu L, et al. Hepatitis C screening in hospitals: find the missing patients. Virol J. 2019;16(1):47.","journal-title":"Virol J"},{"issue":"1","key":"23809_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12879-019-3832-7","volume":"19","author":"H Kileng","year":"2019","unstructured":"Kileng H, Gutteberg T, Goll R, Paulssen EJ. Screening for hepatitis C in a general adult population in a low-prevalence area: the Troms\u00f8 study. BMC Infect Dis. 2019;19(1):189.","journal-title":"BMC Infect Dis"},{"key":"23809_CR33","doi-asserted-by":"crossref","unstructured":"Gardona R, Appel F, Ercolin S, Carvalho-Filho RJ, Barbosa DA, Ferraz ML. Evaluation of a strategy for identification of hepatitis C virus carriers in outpatient and emergency units: contribution to the microelimination of hepatitis C in Brazil. Brazilian J Infect Dis. 2021;25.","DOI":"10.1016\/j.bjid.2021.101546"},{"issue":"7","key":"23809_CR34","doi-asserted-by":"publisher","first-page":"e0198520","DOI":"10.1371\/journal.pone.0198520","volume":"13","author":"H Evans","year":"2018","unstructured":"Evans H, Balasegaram S, Douthwaite S, Hunter L, Kulasegaram R, Wong T, et al. An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London emergency department. PLoS One. 2018;13(7):e0198520.","journal-title":"PLoS One"},{"issue":"3","key":"23809_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jemermed.2020.09.034","volume":"60","author":"EA Cowan","year":"2021","unstructured":"Cowan EA, Dinani A, Br spiegelS, O\u2019Brien-Lambert C, Zaheer J, et al. Nontargeted hepatitis C screening in an urban emergency department in new York City. J Emerg Med. 2021;60(3):299\u2013309.","journal-title":"J Emerg Med"},{"issue":"3","key":"23809_CR36","doi-asserted-by":"publisher","first-page":"719","DOI":"10.5811\/westjem.2021.1.49667","volume":"22","author":"JS Ford","year":"2021","unstructured":"Ford JS, Chechi T, Toosi K, Mahmood B, Meehleis D, Otmar M, et al. Universal screening for hepatitis C virus in the ED using a best practice advisory. West J Emerg Med. 2021;22(3):719\u201325.","journal-title":"West J Emerg Med"},{"issue":"2","key":"23809_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/09691413221086497","volume":"29","author":"M Butsashvili","year":"2022","unstructured":"Butsashvili M, Zurashvili T, Kamkamidze G, Kajaia M, Gulbiani L, Gamezardashvili A, et al. Door-to-door hepatitis C screening in Georgia: an innovative model to increase testing and linkage to care. J Med Screen. 2022;29(2):134\u20136.","journal-title":"J Med Screen"},{"issue":"9","key":"23809_CR38","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/MEG.0000000000001190","volume":"30","author":"LG-E Viejo","year":"2018","unstructured":"Viejo LG-E, Herola AG, Lloret IS, Ruano F, S\u00e1nchez o, Paulino IC, et al. Screening of hepatitis C virus infection in adult general population in Spain. Eur J Gastroenterol Hepatol. 2018;30(9):1077\u201381.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"23809_CR39","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/liv.13519","volume":"38","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Blissett D, Blissett R, Henry L, Younossi Y, Beckerman R, et al. In an era of highly effective treatment, hepatitis C screening of the united States general population should be considered. Liver Int. 2018;38(2):258\u201365.","journal-title":"Liver Int"},{"key":"23809_CR40","unstructured":"Meshkati M, Ataei B, Nokhaodian Z, Yaran M, Babak A, Zadeh MRA et al. Hepatitis C screening in Isfahan drop in centers: an experience description. 2011."},{"issue":"4","key":"23809_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/jpids\/piz065","volume":"9","author":"esND Fern","year":"2020","unstructured":"Fern esND, Banik S, Abughali N, Sthapit B, Abdullah N, et al. Hepatitis C virus screening among adolescents attending a drug rehabilitation center. J Pediatr Infect Dis Soc. 2020;9(4):437\u201341.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"5","key":"23809_CR42","doi-asserted-by":"publisher","first-page":"e0252490","DOI":"10.1371\/journal.pone.0252490","volume":"16","author":"R Didiya","year":"2021","unstructured":"Didiya R, Gyenwali D, Pokhrel TN, Devkota S, Rai AB, Shedain PR, et al. Community led testing among people who inject drugs: a community centered model to find new cases of HIV and hepatitis C in Nepal. PLoS One. 2021;16(5):e0252490.","journal-title":"PLoS One"},{"key":"23809_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103055","volume":"90","author":"V Fiore","year":"2021","unstructured":"Fiore V, De Matteis G, Ranieri R, Saderi L, Pontali E, Muredda A, et al. HCV testing and treatment initiation in an Italian prison setting: a step-by-step model to micro-eliminate hepatitis C. Int J Drug Policy. 2021;90: 103055.","journal-title":"Int J Drug Policy"},{"key":"23809_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00400-4","volume":"17","author":"S Hariri","year":"2020","unstructured":"Hariri S, Sharafkhah M, Alavi M, el Rosh G, Fazel A, et al. A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low-to middle-income setting. Harm Reduct J. 2020;17:1\u20139.","journal-title":"Harm Reduct J"},{"key":"23809_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103668","volume":"103","author":"BP Jacka","year":"2022","unstructured":"Jacka BP, Bazerman LB, Dickerson C, Moody M, Martin J, Patry E, et al. Feasibility of hepatitis C virus testing and linkage in community supervision offices: great potential but persistent challenges. Int J Drug Policy. 2022;103: 103668.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"23809_CR46","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/jvh.13503","volume":"28","author":"L Macgregor","year":"2021","unstructured":"Macgregor L, Ward Z, Martin NK, Nicholls J, Desai M, Hickson F, et al. The cost-effectiveness of case-finding strategies for achieving hepatitis C elimination among men who have sex with men in the UK. J Viral Hepat. 2021;28(6):897\u2013908.","journal-title":"J Viral Hepat"},{"issue":"1","key":"23809_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12916-023-02981-w","volume":"21","author":"C Wang","year":"2023","unstructured":"Wang C, Zhao P, Weideman AM, Xu W, Ong JJ, Jamil MS, et al. Expanding hepatitis C virus test uptake using self-testing among men who have sex with men in China: two parallel randomized controlled trials. BMC Med. 2023;21(1):279.","journal-title":"BMC Med"},{"issue":"6","key":"23809_CR48","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1007\/s10900-019-00679-w","volume":"44","author":"D Fuster","year":"2019","unstructured":"Fuster D, Gelberg L. Community screening, identification, and referral to primary care, for hepatitis C, B, and HIV among homeless persons in Los Angeles. J Community Health. 2019;44(6):1044\u201354.","journal-title":"J Community Health"},{"issue":"1","key":"23809_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3748-2","volume":"19","author":"JS Lambert","year":"2019","unstructured":"Lambert JS, Murtagh R, Menezes D, O\u2019Carroll A, Murphy C, Cullen W, et al. Hepcheck dublin\u2019: an intensified hepatitis C screening programme in a homeless population demonstrates the need for alternative models of care. BMC Infect Dis. 2019;19(1): 128.","journal-title":"BMC Infect Dis"},{"key":"23809_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/00333549161310S210","volume":"131","author":"AC Se\u00f1a","year":"2016","unstructured":"Se\u00f1a AC, Willis SJ, Hilton A, Anderson A, Wohl DA, Hurt CB, et al. Efforts at the frontlines: implementing a hepatitis C testing and linkage-to-care program at the local public health level. Public Health Rep. 2016;131:57\u201364.","journal-title":"Public Health Rep"},{"issue":"5","key":"23809_CR51","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/jvh.12507","volume":"23","author":"O Falade-Nwulia","year":"2016","unstructured":"Falade-Nwulia O, Mehta SH, Lasola J, Latkin C, Niculescu A, O\u2019Connor C, et al. Public health clinic-based hepatitis C testing and linkage to care in Baltimore. J Viral Hepat. 2016;23(5):366\u201374.","journal-title":"J Viral Hepat"},{"key":"23809_CR52","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1186\/s12879-021-06537-2","volume":"21","author":"R Matulionyt\u0117","year":"2021","unstructured":"Matulionyt\u0117 R, Jakobsen ML, Grecu VI, Grigaitiene J, Raudonis T, Stoniene L, et al. Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE joint action pilots in Lithuania, Romania and Spain. BMC Infect Dis. 2021;21:845.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"23809_CR53","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/23744235.2021.1962542","volume":"53","author":"JJ Wentworth","year":"2021","unstructured":"Wentworth JJ, \u00d8vrehus ALH, Hansen JF, Biesenbach P, Christensen PB. Emergency department testing is feasible but ineffective to eliminate hepatitis C in Denmark. Infect Dis (Lond). 2021;53(12):930\u201341.","journal-title":"Infect Dis (Lond)"},{"issue":"2","key":"23809_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/emermed-2019-208637","volume":"37","author":"C Grant","year":"2020","unstructured":"Grant C, O\u2019Connell S, Lillis D, Moriarty A, Fitzgerald I, Dalby L, et al. Opt-out screening for HIV, hepatitis B and hepatitis C: observational study of screening acceptance, yield and treatment outcomes. Emerg Med J. 2020;37(2):102\u20135.","journal-title":"Emerg Med J"},{"issue":"1","key":"23809_CR55","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12879-023-08362-1","volume":"23","author":"D St\u00e4mpfli","year":"2023","unstructured":"St\u00e4mpfli D, Imfeld-Isenegger TL, Hersberger KE, Messerli M. Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot. BMC Infect Dis. 2023;23(1):384.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"23809_CR56","first-page":"97","volume":"29","author":"HA Torres","year":"2021","unstructured":"Torres HA, Lok AS, Suarez-Almazor ME, Warneke CL, Kaseb A, Miller E, et al. Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Support Care Cancer. 2021;29(1):97\u2013105.","journal-title":"Support Care Cancer"},{"key":"23809_CR57","doi-asserted-by":"crossref","unstructured":"Sugiyama A, Fujii T, Nagashima S, Ohisa M, Yamamoto C, Chuon C et al. Pilot study for hepatitis virus screening among employees as an effective approach to encourage employees who screened positive to receive medical care in Japan. 2018:E291\u2013302.","DOI":"10.1111\/hepr.12986"},{"key":"23809_CR58","unstructured":"Woo GA, Hill MA, De Medina MD, Schiff ER. Screening for hepatitis B virus and hepatitis C virus at a community fair: A single-center experience. 2013;293\u20139."},{"key":"23809_CR59","doi-asserted-by":"crossref","unstructured":"Sedrak AS, Salem AA, Hassany M, Elsebaie EHA. Economic analysis of HCV different screening algorithms in Egypt. 2021;2447\u201355 p.","DOI":"10.21608\/ejhm.2021.184667"},{"key":"23809_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.vhri.2018.12.005","volume":"18","author":"L Hiebert","year":"2019","unstructured":"Hiebert L, Hecht R, Soe-Lin S, Mohamed R, Shabaruddin FH, Mansor SMS, et al. A Stepwise approach to a National hepatitis C screening strategy in Malaysia to Meet the WHO 2030 targets: proposed strategy, coverage, and costs. Value Health Reg Issues. 2019;18:112\u201320.","journal-title":"Value Health Reg Issues"},{"key":"23809_CR61","unstructured":"Meshkati M, Ataei B, Nokhaodian Z, Yaran M, Babak A, Zadeh MRA, et al. Hepatitis C screening in Isfahan drop in centers: an experience description. J Isfahan Med Sch. 2011."},{"key":"23809_CR62","doi-asserted-by":"publisher","DOI":"10.3138\/canlivj-2020-0038","author":"M Rai","year":"2021","unstructured":"Rai M, Lowe C, Flemming JA. Screening for hepatitis c in an outpatient endoscopy unit. Canadian Liver Journal. 2021. https:\/\/doi.org\/10.3138\/canlivj-2020-0038.","journal-title":"Canadian Liver Journal"},{"key":"23809_CR63","doi-asserted-by":"crossref","unstructured":"Viejo LG-E, Herola AG, Lloret IS, Ruano FS, Paulino IC, Ivorra CQ et al. Screening of hepatitis C virus infection in adult general population in Spain. Eur J Gastroenterol Hepatol. 2018;1077\u201381.","DOI":"10.1097\/MEG.0000000000001190"},{"issue":"2","key":"23809_CR64","doi-asserted-by":"publisher","first-page":"86","DOI":"10.11622\/smedj.2020116","volume":"63","author":"JC Hsiang","year":"2022","unstructured":"Hsiang JC, Sinnaswami P, Lee MY, Zhang MM, Quek KE, Tan KH, et al. Point-of-care hepatitis C screening with direct access referral to improve linkage to care among halfway house residents: a pilot randomised study. Singap Med J. 2022;63(2):86\u201392.","journal-title":"Singap Med J"},{"key":"23809_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103424","volume":"96","author":"P Ryan","year":"2021","unstructured":"Ryan P, Valencia J, Cuevas G, Torres-Macho J, Troya J, Pueyo \u00c1, et al. Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain. Int J Drug Policy. 2021;96: 103424.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"23809_CR66","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jhep.2023.04.019","volume":"79","author":"Y Sheehan","year":"2023","unstructured":"Sheehan Y, Cunningham EB, Cochrane A, Byrne M, Brown T, McGrath C, et al. A \u2018one-stop-shop\u2019 point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: the PIVOT study. J Hepatol. 2023;79(3):635\u201344.","journal-title":"J Hepatol"},{"key":"23809_CR67","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.drugpo.2019.05.012","volume":"72","author":"B Williams","year":"2019","unstructured":"Williams B, Howell J, Doyle J, Thompson AJ, Draper B, Layton C, et al. Point-of-care hepatitis C testing from needle and syringe programs: an Australian feasibility study. Int J Drug Policy. 2019;72:91\u20138.","journal-title":"Int J Drug Policy"},{"key":"23809_CR68","doi-asserted-by":"crossref","unstructured":"Thompson LA, Fenton J, Charlton CL. HCV reflex testing: A single-sample, low-contamination method that improves the diagnostic efficiency of HCV testing among patients in alberta, Canada. 2022;97\u2013107 p.","DOI":"10.3138\/jammi-2021-0028"},{"issue":"9","key":"23809_CR69","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.eimc.2020.12.019","volume":"40","author":"A Vallejo","year":"2022","unstructured":"Vallejo A, Moldes LM, Trigo M, Ordo\u00f1ez P, Rodriguez-Otero L, Cabrera JJ, et al. Generalized implementation of reflex testing of hepatitis C in galicia: results for reflection. Enferm Infecc Microbiol Clin (Engl Ed). 2022;40(9):483\u20138.","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"issue":"1","key":"23809_CR70","first-page":"10","volume":"111","author":"J Crespo","year":"2019","unstructured":"Crespo J, Eiros-Bouza JM, Blasco-Bravo AJ, Lazaro-de-Mercado P, Aguilera-Guirao A, Garcia F, et al. The efficiency of several one-step testing strategies for the diagnosis of hepatitis C. Revista Esp De Enfermadades Digestivas (REED). 2019;111(1):10\u20137.","journal-title":"Revista Esp De Enfermadades Digestivas (REED)"},{"issue":"1","key":"23809_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13696998.2017.1369983","volume":"21","author":"P J\u00fclicher","year":"2018","unstructured":"J\u00fclicher P, Galli C. Identifying cost-effective screening algorithms for active hepatitis C virus infections in a high prevalence setting. J Med Econ. 2018;21(1):1\u201310.","journal-title":"J Med Econ"},{"key":"23809_CR72","doi-asserted-by":"publisher","first-page":"3449938","DOI":"10.1155\/2022\/3449938","volume":"2022","author":"DS Prince","year":"2022","unstructured":"Prince DS, Girolamo JD, Pipicella JL, Bagatella M, Kayes T, Alvaro F, et al. Finding cases of hepatitis C for treatment using automated screening in the emergency department is effective, but what is the cost?? Can J Gastroenterol Hepatol. 2022;2022:3449938.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"23809_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100750","author":"ST Shih","year":"2023","unstructured":"Shih ST, Cheng Q, Carson J, Valerio H, Sheehan Y, Gray RT, et al. Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis. The Lancet Regional Health\u2013Western Pacific. 2023. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100750.","journal-title":"The Lancet Regional Health\u2013Western Pacific"},{"issue":"1","key":"23809_CR74","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/jvh.12994","volume":"26","author":"MC Duong","year":"2019","unstructured":"Duong MC, McLaws ML. Screening haemodialysis patients for hepatitis C in Vietnam: the inconsistency between common hepatitis C virus serological and virological tests. J Viral Hepat. 2019;26(1):25\u20139.","journal-title":"J Viral Hepat"},{"key":"23809_CR75","unstructured":"Diseases AAftSoL. HCV Guidance: Recommendations for Testing, Managing, and, Treating Hepatitis C. 2022. Available from: https:\/\/www.hcvguidelines.org\/unique-populations\/pregnancy"},{"issue":"28","key":"23809_CR76","doi-asserted-by":"publisher","first-page":"766","DOI":"10.15585\/mmwr.mm7228a2","volume":"72","author":"EJ Cartwright","year":"2023","unstructured":"Cartwright EJ, Patel P, Kamili S, Wester C. Updated operational guidance for implementing CDC\u2019s recommendations on testing for hepatitis C virus infection. MMWR Morb Mortal Wkly Rep. 2023;72(28):766\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"23809_CR77","doi-asserted-by":"crossref","unstructured":"Jones L, Bates G, McCoy E, Beynon C, McVeigh J, Bellis MA. Effectiveness of interventions to increase hepatitis C testing uptake among high-risk groups: A systematic review. Eur J Pub Health. 2013;781\u20138.","DOI":"10.1093\/eurpub\/ckt156"},{"issue":"17","key":"23809_CR78","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.2174\/138161208784746833","volume":"14","author":"A Tramarin","year":"2008","unstructured":"Tramarin A, Gennaro N, Compostella FA, Gallo C, Wendelaar Bonga LJ, Postma MJ. HCV screening to enable early treatment of hepatitis C: a mathematical model to analyse costs and outcomes in two populations. Curr Pharm Des. 2008;14(17):1655\u201360.","journal-title":"Curr Pharm Des"},{"issue":"11","key":"23809_CR79","first-page":"628","volume":"18","author":"A-K Finbr\u00e5ten","year":"2022","unstructured":"Finbr\u00e5ten A-K, Eckhardt BJ, Kapadia SN, Marks KM. Rapid treatment initiation for hepatitis C virus infection: potential benefits, current limitations, and real-world examples. Gastroenterol Hepatol. 2022;18(11):628.","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"23809_CR80","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1471-2334-14-74","volume":"14","author":"BL Norton","year":"2014","unstructured":"Norton BL, Voils CI, Timberlake SH, Hecker EJ, Goswami ND, Huffman KM, et al. Community-based HCV screening: knowledge and attitudes in a high risk urban population. BMC Infect Dis. 2014;14(1):74.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"23809_CR81","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12954-023-00743-8","volume":"20","author":"M Di Ciaccio","year":"2023","unstructured":"Di Ciaccio M, Villes V, Perfect C, El Kaim JL, Donatelli M, James C, et al. Need for integration of hepatitis C (HCV) services in community-based settings for people who inject drugs: results from a global values and preferences survey. Harm Reduct J. 2023;20(1):15.","journal-title":"Harm Reduct J"},{"key":"23809_CR82","unstructured":"Care UoLH. Why baby boomers? 2022. Available from: https:\/\/uihc.org\/health-topics\/ask-expert-why-should-baby-boomers-get-tested-hepatitis-c.\u00a0"},{"issue":"4","key":"23809_CR83","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s11524-012-9730-6","volume":"90","author":"L Topp","year":"2013","unstructured":"Topp L, Iversen J, Baldry E, Maher L. On behalf of the collaboration of Australian N. Housing instability among people who inject drugs: results from the Australian needle and syringe program survey. J Urb Health. 2013;90(4):699\u2013716.","journal-title":"J Urb Health"},{"issue":"3","key":"23809_CR84","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10461-005-9000-7","volume":"9","author":"A Aidala","year":"2005","unstructured":"Aidala A, Cross JE, Stall R, Harre D, Sumartojo E. Housing status and HIV risk behaviors: implications for prevention and policy. AIDS Behav. 2005;9(3):251\u201365.","journal-title":"AIDS Behav"},{"issue":"5","key":"23809_CR85","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/14787210.2019.1604221","volume":"17","author":"S Chevaliez","year":"2019","unstructured":"Chevaliez S. Strategies for the improvement of HCV testing and diagnosis. Expert Rev anti-infective Therapy. 2019;17(5):341\u20137.","journal-title":"Expert Rev anti-infective Therapy"},{"issue":"8","key":"23809_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102589","volume":"19","author":"C Mazzaro","year":"2020","unstructured":"Mazzaro C, Dal Maso L, Mauro E, Visentini M, Tonizzo M, Gattei V, et al. Hepatitis C virus-related cryoglobulinemic vasculitis: a review of the role of the new direct antiviral agents (DAAs) therapy. Autoimmun Rev. 2020;19(8): 102589.","journal-title":"Autoimmun Rev"},{"issue":"12","key":"23809_CR87","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S1473-3099(18)30469-9","volume":"18","author":"J Stone","year":"2018","unstructured":"Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, et al. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18(12):1397\u2013409.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"23809_CR88","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12954-018-0269-z","volume":"15","author":"D Crowley","year":"2018","unstructured":"Crowley D, Van Hout MC, Lambert JS, Kelly E, Murphy C, Cullen W. Barriers and facilitators to hepatitis C (HCV) screening and treatment\u2014a description of prisoners\u2019 perspective. Harm Reduct J. 2018;15(1):62.","journal-title":"Harm Reduct J"},{"issue":"3","key":"23809_CR89","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/hep4.1646","volume":"5","author":"AA Patel","year":"2021","unstructured":"Patel AA, Bui A, Prohl E, Bhattacharya D, Wang S, Branch AD, et al. Innovations in hepatitis C screening and treatment. Hepatol Commun. 2021;5(3):371\u201386.","journal-title":"Hepatol Commun"},{"issue":"13","key":"23809_CR90","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1007\/s11606-022-07628-9","volume":"37","author":"AE Wang","year":"2022","unstructured":"Wang AE, Hsieh E, Turner BJ, Terrault N. Integrating management of hepatitis C infection into primary care: the key to hepatitis C elimination efforts. J Gen Intern Med. 2022;37(13):3435\u201343.","journal-title":"J Gen Intern Med"},{"key":"23809_CR91","unstructured":"WHO. WHO prequalifies the first self-test for hepatitis C virus 2024 [Available from: https:\/\/www.who.int\/news\/item\/10-07-2024-who-prequalifies-the-first-self-test-for-hepatitis-c-virus"},{"issue":"11\u201312","key":"23809_CR92","doi-asserted-by":"publisher","first-page":"540","DOI":"10.14745\/ccdr.v48i1112a07","volume":"48","author":"N Popovic","year":"2022","unstructured":"Popovic N, Williams A, P\u00e9rinet S, Campeau L, Yang Q, Zhang F, et al. National hepatitis C estimates: incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019. Can Commun Dis Rep. 2022;48(11\u201312):540\u20139.","journal-title":"Can Commun Dis Rep"},{"key":"23809_CR93","unstructured":"ECDC ECfDPaC. Hepatitis C Annual Epidemiological Report. 2021."},{"key":"23809_CR94","doi-asserted-by":"crossref","unstructured":"Aguilera A, Fuentes A, Cea M, Carracedo R, Vi\u00f1uela L, Ord\u00f3\u00f1ez P, et al. Real-life validation of a sample pooling strategy for screening of hepatitis C. Clin Microbiol Infect. 2023;29(1):112. e1-. e4. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8266286\/.","DOI":"10.1016\/j.cmi.2022.09.006"},{"issue":"8","key":"23809_CR95","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S2468-1253(21)00217-X","volume":"6","author":"A Aguilera","year":"2021","unstructured":"Aguilera A, Pereira S, Fuentes A, de Salazar A, Trastoy R, Navarro D, et al. Pooling samples for hepatitis C RNA detection. Lancet Gastroenterol Hepatol. 2021;6(8):608\u20139.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"23809_CR96","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cgh.2019.04.035","volume":"18","author":"S Seo","year":"2020","unstructured":"Seo S, Silverberg MJ, Hurley LB, Ready J, Saxena V, Witt D, et al. Prevalence of spontaneous clearance of hepatitis C virus infection doubled from 1998 to 2017. Clin Gastroenterol Hepatol. 2020;18(2):511\u20133.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"23809_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2773-2","volume":"17","author":"W Tang","year":"2017","unstructured":"Tang W, Chen W, Amini A, Boeras D, Falconer J, Kelly H, et al. Diagnostic accuracy of tests to detect hepatitis C antibody: a meta-analysis and review of the literature. BMC Infect Dis. 2017;17(Suppl 1): 695.","journal-title":"BMC Infect Dis"},{"issue":"5B","key":"23809_CR98","doi-asserted-by":"publisher","first-page":"s65","DOI":"10.1002\/hep.1840360709","volume":"36","author":"J-M Pawlotsky","year":"2002","unstructured":"Pawlotsky J-M. Use and interpretation of virological tests for hepatitis C. Hepatology. 2002;36(5B):s65\u201373.","journal-title":"Hepatology"},{"issue":"18","key":"23809_CR99","first-page":"362","volume":"62","author":"CDC","year":"2013","unstructured":"CDC. Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep. 2013;62(18):362\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"23809_CR100","unstructured":"CDC. Updated Operational Guidance for Implementing CDC\u2019s Recommendations on Testing for Hepatitis C Virus Infection. 2023."},{"key":"23809_CR101","doi-asserted-by":"crossref","unstructured":"Wang Y, Jie W, Ling J, Yuanshuai H. HCV core antigen plays an important role in the fight against HCV as an alternative to HCV-RNA detection. J Clin Lab Anal. 2021;35(6):e23755. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcla.23755.","DOI":"10.1002\/jcla.23755"},{"issue":"3","key":"23809_CR102","first-page":"175","volume":"36","author":"R Alonso","year":"2018","unstructured":"Alonso R, P\u00e8c F, L\u00f3pez-Roa P, Alcal\u00e1 L, Rode\u00f1o P, Bouza E. HCV core-antigen assay as an alternative to HCV RNA quantification: a correlation study for the assessment of HCV viremia. Enfermedades Infecciosas Y Microbiol Clin (English ed). 2018;36(3):175\u20138.","journal-title":"Enfermedades Infecciosas Y Microbiol Clin (English ed)"},{"issue":"1","key":"23809_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43066-021-00146-z","volume":"11","author":"O Kallala","year":"2021","unstructured":"Kallala O, Kacem S, Fodha I, Pozzetto B, Abdelhalim T. Role of hepatitis C virus core antigen assay in hepatitis C care in developing country. Egypt Liver J. 2021;11(1):1\u20136.","journal-title":"Egypt Liver J"},{"issue":"3 Suppl 1","key":"23809_CR104","doi-asserted-by":"publisher","first-page":"s48","DOI":"10.1002\/hep.510260709","volume":"26","author":"AS Lok","year":"1997","unstructured":"Lok AS, Gunaratnam NT. Diagnosis of hepatitis C. Hepatology. 1997;26(3 Suppl 1):s48\u201356.","journal-title":"Hepatology"},{"issue":"3","key":"23809_CR105","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1128\/JCM.01511-10","volume":"49","author":"S Laperche","year":"2011","unstructured":"Laperche S, Bouchardeau F, Andr\u00e9-Garnier E, Thibault V, Roque-Afonso AM, Trimoulet P, et al. Interpretation of real-time PCR results for hepatitis C virus RNA when viral load is below quantification limits. J Clin Microbiol. 2011;49(3):1113\u20135.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23809-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-23809-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23809-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T07:30:53Z","timestamp":1757316653000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-23809-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23809"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-23809-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2589"}}